Upadacitinib Improves Patient-Reported Outcomes in bDMARD-Refractory RA
Investigators found data that showed upadacitinib improved patient-reported outcomes.
Investigators found data that showed upadacitinib improved patient-reported outcomes.
Researchers found data that showed the use of the biosimilar infliximab resulted in appreciable cost savings compared with golimumab in the treatment of rheumatoid arthritis.
Researchers found data that showed an association between the development of rheumatoid arthritis and exposure to animal dust in both men and women, but in women there was a risk associated with textile dust.
Improvement is needed in shared decision-making in the treatment of RA, according to researchers in The Netherlands.
Investigators found data that showed the superiority of sarilumab monotherapy over adalimumab in both clinical and functional domains.
Researchers found data that showed using the semiquantitative ultrasound score in the assessment of finger joint cartilage damage caused by rheumatoid arthritis is effective.
Investigators found data that showed magnetic resonance imaging measurements might predict treatment response in rheumatoid arthritis.
Researchers compared effectiveness of certolizumab pegol plus conventional synthetic DMARDs in patients with rheumatoid arthritis, followed by continuing vs discontinuing background csDMARDs after treatment response.
Twelve weeks of lovastatin in patients with mildly active RA had no adjunctive therapeutic effects.
Education about taking medication during pregnancy is needed to better support decisions among women with rheumatoid arthritis.